Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 6, 2025 to Discuss Your Rights – ALT
(NasdaqGM:ALT), NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Altimmune investors who were adversely affected by alleged securities fraud between August 10, 2023 […]